Inflammation, Morbidity and Mortality in Treated HIV: Roles of Asymptomatic CMV and Sex Differences

Peter W. Hunt, MD
Professor of Medicine, Division of Experimental Medicine, UCSF
Co-Director of Basic/Translational Sciences, Center for AIDS Research
San Francisco, CA

Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2021. All rights reserved.



VIDEOTop of page

How to Obtain CME Credit:Top of page

About the Presenter:Top of page

Peter Hunt’s primary research focus is on the inflammatory consequences of HIV infection. His translational research program seeks to understand both the causes and consequences of persistent immune activation in treated HIV infection, including its impact on age-related morbidity and mortality as well as HIV persistence. He also conducts pilot clinical trials of novel immune-based interventions designed to decrease immune activation and recently completed a term as Chair of the Inflammation Committee of the AIDS Clinical Trials Group (ACTG). His laboratory’s more recent work has focused on the impact of the inflammatory state on vaccine responsiveness and on the contribution of asymptomatic CMV infection to multiple inflammatory pathways in treated HIV infection. This latter work has led to a large clinical trial in the ACTG (A5383) and multiple linked NIH grants.

Learning Objectives: Top of page

At the completion of this educational session, participants will:
1. Understand the potential impact of asymptomatic CMV and other herpesvirus replication on the inflammatory state in treated HIV infection.
2. To understand the potential contributions of CMV-associated inflammation to end organ disease in treated HIV infection and the landscape of planned clinical trials that will shed light on these issues.
3. To understand sex differences in the inflammatory state in treated HIV infection and how they may impact morbidity risk.

CME Information:Top of page


This CME activity has approved for AMA PRA Category 1 Credit™ for June 23, 2021 as a live activity.  This activity will also be available as an enduring activity from June 24, 2021, through June 22, 2024.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.

- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.

- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.

- Dr. Peter W. Hunt (Presenter) has no relevant financial relationships to disclose. Dr. Hunt will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Evaluation

You must be logged in to post a comment. Login | Register